Abiopharma

🔍 SACHS DAVID A (Director)

Company: TEREX CORP (TEX)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 3,760 shares of Common Stock, par value $.01 at $71.81 per share (Direct)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 279,590.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock, par value $.01 (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By family LLC | shares_owned_after: 137,500.00
• Holds 0 shares of Common Stock, par value $.01 (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By Wife | shares_owned_after: 8,300.00 | Footnotes: F3

Footnotes:

• F1: Shares granted pursuant to one of the Company's long-term incentive plans representing payment of annual director retainer.
• F2: Ownership includes shares received as a dividend.
• F3: Mr. Sachs disclaims the beneficial ownership of such shares.